TY - JOUR
T1 - Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders
AU - Basile, Umberto
AU - Napodano, Cecilia
AU - Pocino, Krizia
AU - Barini, Angelina
AU - Marino, Mariapaola
AU - Santini, Stefano Angelo
AU - Stefanile, Annunziata
AU - Basile, V.
AU - Calla', Cinzia Anna Maria
AU - Cattani Franchi, Paola
AU - Gasbarrini, Antonio
AU - Rapaccini, Gian Ludovico
AU - Gulli, F.
PY - 2019
Y1 - 2019
N2 - OBJECTIVE: A still uncertain association between Vitamin D levels and HCV chronic liver diseases has been reported. Increased levels of serum-ree light chains (FLCs) and an altered k/λ FLC ratio correlate with Mixed Cryoglobulinemia (MC) vasculitis and/or B-cell non-Hodgkin’s lymphoma in HCV-positive patients. We aimed to investigate the possible role of Vitamin D, Vitamin D Binding Protein (DBP), and FLCs levels as a tool for discriminating different stages of HCV- related MC and chronic liver diseases. PATIENTS AND METHODS: Sixty-five untreated patients were retrospectively enrolled and 21 healthy blood donors (HBD) were used as controls. Vitamin D, DBP, FLCs, and cryoglobulins levels were measured. Based on cryoglobulins, patients were divided in three subgroups (without cryoglobulins, type II, and type III). RESULTS: We didn’t find any significant differences in Vitamin D and DBP levels between HCV patients’ main groups and HBD. Serum FLCs levels were significantly higher in HCV patients than in HBD. FLCs ratio among patients’ subgroups did not reveal differences. CONCLUSIONS: Our results confirm the presence of an increased serum level of FLCs in HCV patients and suggest that nor Vitamin D and DBP or FLC levels can be considered reliable biomarkers for discriminating different stages of HCV-associated chronic liver diseases and/or HCV-associated extrahepatic manifestation. We confirm that serological FLCs levels are significantly higher in patients than in HBD as a signature of B cell activation in course of HCV infection.
AB - OBJECTIVE: A still uncertain association between Vitamin D levels and HCV chronic liver diseases has been reported. Increased levels of serum-ree light chains (FLCs) and an altered k/λ FLC ratio correlate with Mixed Cryoglobulinemia (MC) vasculitis and/or B-cell non-Hodgkin’s lymphoma in HCV-positive patients. We aimed to investigate the possible role of Vitamin D, Vitamin D Binding Protein (DBP), and FLCs levels as a tool for discriminating different stages of HCV- related MC and chronic liver diseases. PATIENTS AND METHODS: Sixty-five untreated patients were retrospectively enrolled and 21 healthy blood donors (HBD) were used as controls. Vitamin D, DBP, FLCs, and cryoglobulins levels were measured. Based on cryoglobulins, patients were divided in three subgroups (without cryoglobulins, type II, and type III). RESULTS: We didn’t find any significant differences in Vitamin D and DBP levels between HCV patients’ main groups and HBD. Serum FLCs levels were significantly higher in HCV patients than in HBD. FLCs ratio among patients’ subgroups did not reveal differences. CONCLUSIONS: Our results confirm the presence of an increased serum level of FLCs in HCV patients and suggest that nor Vitamin D and DBP or FLC levels can be considered reliable biomarkers for discriminating different stages of HCV-associated chronic liver diseases and/or HCV-associated extrahepatic manifestation. We confirm that serological FLCs levels are significantly higher in patients than in HBD as a signature of B cell activation in course of HCV infection.
KW - Free light chains
KW - HCV disorders
KW - Vitamin D
KW - Vitamin D binding protein
KW - Free light chains
KW - HCV disorders
KW - Vitamin D
KW - Vitamin D binding protein
UR - http://hdl.handle.net/10807/145074
UR - https://www.europeanreview.org/wp/wp-content/uploads/8506-8514.pdf
U2 - 10.26355/eurrev_201910_19164
DO - 10.26355/eurrev_201910_19164
M3 - Article
SN - 1128-3602
VL - 23
SP - 8506
EP - 8514
JO - European Review for Medical and Pharmacological Sciences
JF - European Review for Medical and Pharmacological Sciences
ER -